ANAHEIM, Calif., Nov. 18, 2010 /PRNewswire/ -- Crescent Healthcare today announced a planned expansion of their east coast operations in 2011. They signed a lease to open an infusion pharmacy in Totowa, New Jersey, central to providing immune globulin therapies and services to current patients in Massachusetts, Maryland, New York, New Jersey, Pennsylvania, Connecticut, Delaware, District of Columbia, and Rhode Island.
In addition to supporting current business in the northeast, the new facility will provide opportunities for Crescent Healthcare to better serve prospective payer, hospital, and physician customers ordering I.V. and subcutaneous immune globulin (IVIG and SCIG) therapies.
"A local presence will allow us to provide expanded services to clinician customers and patients in the northeast," said Leslie Vaughan, RPh, Senior Vice President Chronic Therapy Division. "It will also provide a base from which to expand our value-based partnership model, Medical Management Solutions, which we originated in California."
About Crescent Healthcare
Crescent Healthcare, Inc. (http://www.crescenthealthcare.com) manages and delivers integrated pharmacy and nursing services to patients in alternate site settings. The company delivers care through the implementation of innovative partnerships with health plans, hospitals, and medical groups to manage patient populations to the best clinical and financial outcomes. Founded in 1992, Crescent Healthcare is contracted with hundreds of payers and treats thousands of acute and chronic patients nationwide each month. Accredited by the Accreditation Commission for Health Care (ACHC), Crescent Healthcare is committed to delivering exceptional quality care that is both appropriate and cost effective.FOR INFORMATION:
Craig Fischer, Pharm. D., SVP Corporate DevelopmentDay: 714.520.6374cfischer@crescenthh
|SOURCE Crescent Healthcare, Inc.|
Copyright©2010 PR Newswire.
All rights reserved